%0 Journal Article
%T A randomised study of the impact of the SGLT2 inhibitor dapagliflozin on microvascular and macrovascular circulation
%A Agnes Jumar
%A Christian Ott
%A Kristina Striepe
%A Marina V. Karg
%A Peter Bramlage
%A Roland E. Schmieder
%A Stefanie Friedrich
%J Archive of "Cardiovascular Diabetology".
%D 2017
%R 10.1186/s12933-017-0510-1
%X The sodium¨Cglucose cotransporter 2 inhibitor, dapagliflozin, has been shown to improve diabetic control and reduce blood pressure in patients with type 2 diabetes mellitus. Its effects on micro- and macrovascular structure and function have not yet been reported
%K Arterial remodelling
%K Pulse wave analysis
%K Insulin resistance
%K SGLT2 inhibitors
%K Blood pressure
%K Scanning laser Doppler flowmetry
%K vascular protection
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5324272/